Evaluation of dopamine D 2/3specific binding in the cerebellum for the positron emission tomography radiotracer [ 11C]FLB 457: Implications for measuring cortical dopamine release

Synapse

Volumn 65, Issue 10, 2011, Pages 991-997

  Narendran, Rajesh ^a   Mason, N Scott ^a   Chen, Chi Min ^a   Himes, Michael ^a   Keating, Patrick ^a   May, Maureen A ^a   Rabiner, Eugenii A ^b,c   Laruelle, Marc ^c,d   Mathis, Chester A ^a   Frankle, W Gordon ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

11C FLB 457; D 2 3 receptors; Dopamine; Human cortex; Positron emission tomography

Indexed keywords

ARIPIPRAZOLE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ISOREMOXIPRIDE; ISOREMOXIPRIDE C 11; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN CORTEX; CEREBELLUM; DOPAMINE RELEASE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROIMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; SIGNAL DETECTION; SINGLE DRUG DOSE;

ADULT; ANTIPSYCHOTIC AGENTS; BINDING, COMPETITIVE; CARBON RADIOISOTOPES; CEREBELLUM; CEREBRAL CORTEX; DOPAMINE; FEMALE; HUMANS; MALE; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; QUINOLONES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SALICYLAMIDES; YOUNG ADULT;

EID: 79960956705     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20926     Document Type: Article

References (19)

1. Aalto S, Hirvonen J, Kaasinen V, Hagelberg N, Kajander J, Nagren K, Seppala T, Rinne JO, Scheinin H, Hietala J. 2009. The effects of D-amphetamine on extrastriatal dopamine D(2)/D (3) receptors: A randomized, double-blind, placebo-controlled PET study with [(11)C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging 36: 472-474.
2. Abi-Dargham A, Laruelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Bremner JD, Hyde TM, Charney DS, Hoffer PB, Innis RB. 1994. SPECT measurement of benzodiazepine receptors in human brain with [123-I]iomazenil: Kinetic and equilibrium paradigms. J Nucl Med 35: 228-238.
3. Abi-Dargham A, Simpson N, Kegeles L, Parsey R, Hwang DR, Anjilvel S, Zea-Ponce Y, Lombardo I, Van Heertum R, Mann JJ, Foged C, Halldin C, Laruelle M. 1999. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756. Synapse 32: 93-109.
4. Asselin MC, Montgomery AJ, Grasby PM, Hume SP. 2007. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: Re-evaluation of the validity of using a cerebellar reference region. J Cereb Blood Flow Metab 27: 378-392.
5. Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN. 2010. Measuring drug occupancy in the absence of a reference region: The Lassen plot re-visited. J Cereb Blood Flow Metab 30: 46-50.
6. Delforge J, Bottlaender M, Loc'h C, Guenther I, Fuseau C, Bendriem B, Syrota A, Maziere B. 1999. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab 19: 533-546.
7. Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, Halldin C. 1997. A PET study of [C-11]FLB 457 binding to extrastriatal D-2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology 133: 396-404.
8. Grunder G, Fellows C, Janouschek H, Veselinovic T, Boy C, Brocheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rosch F, Schaefer WM, Vernaleken I. 2008. Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: An [18F]fallypride PET study. Am J Psychiatry 165: 988-995.
9. Halldin C, Farde L, Hogberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG. 1995. Carbon-11-FLB 457: A radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 36: 1275-1281.
10. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
11. Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A. 2008. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology 33: 3111-3125.
12. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. 1984. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15: 217-227.
13. Montgomery AJ, Asselin MC, Farde L, Grasby PM. 2007. Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [(11)C]FLB 457 PET. J Cereb Blood Flow Metab 27: 369-377.
14. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M. 2009. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 63: 447-461.
15. Narendran R, Mason NS, May MA, Chen CM, Kendro S, Ridler K, Rabiner EA, Laruelle M, Mathis CA, Frankle WG. 2010. PET imaging of dopamine D(2/3) receptors in the human cortex with [(11)C]FLB 457: Reproducibility studies. Synapse 65: 35-40.
16. Olsson H, Halldin C, Swahn CG, Farde L. 1999. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab 19: 1164-1173.
17. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM, 2004. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (Suppl 1): S208-S219.
18. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, Halldin C, Farde L. 2001. Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 22: 1215-1221.
19. Zhang Y, Brady M, Smith S. 2001. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57.